Management

CHIEF EXECUTIVE OFFICER
Hugh O’Dowd, M.B.A.
Neon Therapeutics’ chief executive officer, Hugh O’Dowd, joined the company in 2016, bringing more than 20 years of expertise in pharmaceutical leadership and moving important oncology therapies from clinical development through commercialization. Hugh joined Neon Therapeutics from Novartis
CHIEF FINANCIAL OFFICER
Yasir Al-Wakeel, B.M., B.Ch.
Yasir B. Al-Wakeel joined Neon Therapeutics in 2017 as the company’s chief financial officer. Prior to Neon, Yasir served as chief financial officer and head of corporate development of Merrimack Pharmaceuticals, where he spearheaded the strategic sale of Onivyde® and a generic version of Doxil® to
CHIEF BUSINESS OFFICER
Robert Ang, M.D., M.B.A.
Robert Ang is Neon’s chief business officer. Prior to Neon, Robert served as senior vice president of business development at Bavarian Nordic, an international biotechnology company developing and manufacturing novel cancer immunotherapies and vaccines for infectious diseases.
PRESIDENT OF RESEARCH & DEVELOPMENT
Richard Gaynor, M.D.
Richard Gaynor joined Neon Therapeutics in 2016. Previously, from 2013 until his departure in 2016, he held the position of senior vice president of global product development and medical affairs at Lilly Oncology. Richard began his career in academia, spending nine years on the faculty at UCLA
VICE PRESIDENT OF PRODUCT DEVELOPMENT
Kelledy Manson
Kelledy Manson joined Neon as the company’s vice president of product development in 2015. She has nearly 25 years of experience in the biopharmaceutical industry, having been involved in all aspects of development in addition to program and alliance management.  Prior to Neon, Kelledy held
VICE PRESIDENT OF HUMAN RESOURCES
Teresa Regan
Teresa (Terry) Regan joined Neon Therapeutics in 2017 as vice president of human resources. Terry has over 20 years of human resources experience in the biotechnology space.  Prior to Neon, from 2012 to 2017, Terry was a sought-after consultant who provided HR leadership, including executive
VICE PRESIDENT, GENERAL COUNSEL
SIEGEL
Jolie M. Siegel joined Neon Therapeutics in 2018 as the company’s vice president, general counsel. Most recently, Jolie served as senior vice president, deputy general counsel and assistant secretary of Intralinks, a leading and publicly-traded financial technology provider for the global banking,